Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche Blinks But Is $93 Enough For Genentech Shareholders?

Mar 06 2009

• By The Pink Sheet Daily

Related Content

Roche’s High-Stakes Gambit For Genentech

Jan 30 2009

Roche Finally Gets Nod With Sweetened $3.4 Billion Bid For Ventana

Jan 28 2008

After Roche/Genentech: Pharma's Focus on Efficiencies, Not Innovation

Jul 01 2008

The Genentech Sales Pitch: Higher Values R Us

Mar 02 2009

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window